Authors: Roter, DL Stashefsky-Margalit, R Rudd, R

Citation: Dl. Roter et al., Current perspectives on patient education in the US, PAT EDUC C, 44(1), 2001, pp. 79-86

Authors: Kruse, D Pantelis, C Rudd, R Quek, J Herbert, P McKinley, M

Citation: D. Kruse et al., Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug(irbesartan) (vol 35, pg 65, 2001), AUST NZ J P, 35(3), 2001, pp. 419-419

Authors: Kruse, D Pantelis, C Rudd, R Quek, J Herbert, P McKinley, M

Citation: D. Kruse et al., Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug(irbesartan), AUST NZ J P, 35(1), 2001, pp. 65-68

Authors: Emmons, KM Koch-Weser, S Atwood, K Conboy, L Rudd, R Colditz, G

Citation: Km. Emmons et al., A qualitative evaluation of the Harvard Cancer Risk Index, J HEAL COMM, 4(3), 1999, pp. 181-193

Authors: Roter, D Rudd, R Koch-Weser, S

Citation: D. Roter et al., Health literacy and the JAMA Patient Page, J AM MED A, 282(6), 1999, pp. 526-526

Authors: Joel, S O'Byrne, K Penson, R Papamichael, D Higgins, A Robertshaw, H Rudd, R Talbot, D Slevin, M

Citation: S. Joel et al., A randomised, concentration-controlled, comparison of standard (5-day) vs.prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer, ANN ONCOL, 9(11), 1998, pp. 1205-1211